NEXGEL, Inc. (NXGL), a company specializing in medical and over-the-counter (OTC) products, has announced the appointment of Joseph McGuire as its new Chief Financial Officer, effective January 1, 2025. The current CFO, Adam Drapczuk III, will transition to a consulting role, aligning with his plans to develop his consulting practice under Achieving Consulting Excellence, LLC.
Joseph McGuire brings over three decades of experience in financial management and public company operations, having held CFO roles across both private and publicly traded entities spanning health care, financial services, investment, and manufacturing sectors. His notable achievements include playing an instrumental role in the successful IPO of a biotechnology firm, which secured its listing on the NYSE in July 2022. McGuire's career began at Price Waterhouse as a certified public accountant, followed by leadership roles at Dean Witter Reynolds and Paine Webber, Inc.
Since September 2, 2024, McGuire has been consulting with NEXGEL and will continue to drive financial strategy and operations as part of the executive management team.
